Elanco Animal Health (ELAN) Tops Q3 EPS by 6c; offers outlook

Elanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Elanco Animal Health sees Q4 2023 EPS of $0.07-$0.13, versus the consensus of $0.11. Elanco Animal Health sees Q4 2023 revenue of $978 million to 1.02 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Elanco Animal Health (ELAN) PT Raised to $32 at TD Cowen; Names Best Smidcap Idea
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• Goldman Sachs Starts Chagee Holdings (CHA) at Neutral